Nanobiotix S.A. (NBTX)Healthcare | Biotechnology | Paris, France | NasdaqGS
33.79 USD
+1.33
(4.097%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 33.79 Short-term: ★★★★☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 1:23 p.m. EDT
NBTX shows short-term momentum with recent price gains and positive news flow, but long-term fundamentals are weak with high negative profit margins and low analyst coverage. No dividend history indicates lack of yield. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.280568 |
| AutoETS | 0.285185 |
| MSTL | 0.285586 |
| AutoARIMA | 0.304652 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 45% |
| H-stat | 8.41 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.418 |
| Excess Kurtosis | -0.58 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.682 |
| Market Cap | 1,638,663,424 |
| Forward P/E | 462.28 |
| Beta | 0.55 |
| Profit Margins | -73.52% |
| Website | https://www.nanobiotix.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 9.451593 |
| Address1 | 60 rue de Wattignies |
| All Time High | 41.89 |
| All Time Low | 1.75 |
| Ask | 34.45 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 61,640 |
| Average Daily Volume3 Month | 49,729 |
| Average Volume | 49,729 |
| Average Volume10Days | 61,640 |
| Beta | 0.546 |
| Bid | 33.49 |
| Bid Size | 1 |
| Book Value | -1.6549962 |
| City | Paris |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | France |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 33.79 |
| Current Ratio | 1.091 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 34.46 |
| Day Low | 33.24 |
| Display Name | Nanobiotix |
| Earnings Call Timestamp End | 1,775,044,800 |
| Earnings Call Timestamp Start | 1,775,044,800 |
| Earnings Timestamp | 1,774,987,200 |
| Earnings Timestamp End | 1,774,987,200 |
| Earnings Timestamp Start | 1,774,987,200 |
| Ebitda | -10,489,000 |
| Ebitda Margins | -0.32182 |
| Enterprise To Ebitda | -159.939 |
| Enterprise To Revenue | 51.471 |
| Enterprise Value | 1,677,597,824 |
| Eps Current Year | -0.24004 |
| Eps Forward | 0.0730949 |
| Eps Trailing Twelve Months | -0.59 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 33 1 40 26 04 44 |
| Fifty Day Average | 30.061 |
| Fifty Day Average Change | 3.729 |
| Fifty Day Average Change Percent | 0.12404777 |
| Fifty Two Week Change Percent | 945.15936 |
| Fifty Two Week High | 41.89 |
| Fifty Two Week High Change | -8.099998 |
| Fifty Two Week High Change Percent | -0.19336353 |
| Fifty Two Week Low | 3.118 |
| Fifty Two Week Low Change | 30.672 |
| Fifty Two Week Low Change Percent | 9.837075 |
| Fifty Two Week Range | 3.118 - 41.89 |
| Financial Currency | EUR |
| First Trade Date Milliseconds | 1,607,697,000,000 |
| Float Shares | 31,058,290 |
| Forward Eps | 0.0730949 |
| Forward P E | 462.2758 |
| Free Cashflow | -7,894,125 |
| Full Exchange Name | NasdaqGS |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 1.0 |
| Gross Profits | 32,593,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0 |
| Held Percent Institutions | 0.117860004 |
| Implied Shares Outstanding | 48,495,512 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,020-12-11 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France. |
| Long Name | Nanobiotix S.A. |
| Market | us_market |
| Market Cap | 1,638,663,424 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_20950715 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -23,961,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,639,566,205 |
| Number Of Analyst Opinions | 4 |
| Open | 33.85 |
| Operating Cashflow | -33,422,000 |
| Operating Margins | -1.9642301 |
| Payout Ratio | 0.0 |
| Phone | 33 1 40 26 04 70 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 33.79 |
| Post Market Time | 1,776,456,604 |
| Previous Close | 32.46 |
| Price Eps Current Year | -140.7682 |
| Price Hint | 2 |
| Price To Book | -20.416965 |
| Price To Sales Trailing12 Months | 50.276546 |
| Profit Margins | -0.73516 |
| Quick Ratio | 1.051 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 1.33 |
| Regular Market Change Percent | 4.09736 |
| Regular Market Day High | 34.46 |
| Regular Market Day Low | 33.24 |
| Regular Market Day Range | 33.24 - 34.46 |
| Regular Market Open | 33.85 |
| Regular Market Previous Close | 32.46 |
| Regular Market Price | 33.79 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 61,502 |
| Return On Assets | -0.10063 |
| Revenue Per Share | 0.682 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 48,495,512 |
| Shares Percent Shares Out | 0.0005 |
| Shares Short | 25,474 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 15,389 |
| Short Name | Nanobiotix S.A. |
| Short Percent Of Float | 0.0007 |
| Short Ratio | 0.36 |
| Source Interval | 15 |
| Symbol | NBTX |
| Target High Price | 37.761826 |
| Target Low Price | 26.250883 |
| Target Mean Price | 33.361084 |
| Target Median Price | 34.715813 |
| Total Cash | 52,750,000 |
| Total Cash Per Share | 1.09 |
| Total Debt | 95,319,000 |
| Total Revenue | 32,593,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.59 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 19.628084 |
| Two Hundred Day Average Change | 14.161917 |
| Two Hundred Day Average Change Percent | 0.7215129 |
| Type Disp | Equity |
| Volume | 61,502 |
| Website | https://www.nanobiotix.com |
| Zip | 75,012 |